Effect of Dabigatran on Coagulation Parameters in Patients Undergoing Elective Orthopaedic Surgery.
Phase of Trial: Phase IV
Latest Information Update: 01 Aug 2016
At a glance
- Drugs Dabigatran etexilate (Primary)
- Indications Thromboembolism
- Focus Pharmacodynamics
- 07 Apr 2011 Actual end date (Apr 2011) added as reported by ClinicalTrials.gov.
- 07 Apr 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 06 May 2010 New trial record